Purchase order 4800176677

The University of Nebraska Medical Center (UNMC), a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order valued at $32,888.94 to Duke University's Duke Human Vaccine Institute (DHVI) on February 5, 2026. The contract period spans four days, with delivery scheduled for February 9, 2026, to UNMC's Shipping and Receiving facility in Omaha, Nebraska. Payment terms are Net 30, with freight prepaid by the vendor and F.O.B. Destination pricing.

The purchase order encompasses vaccine-related research materials consisting of four distinct line items. These include four units of CH505TFchim.6R.SOSIP.664v4.1/293F at $4,089.18 each; two units of CH505.M5 G458Y SOSIP/GnTI at $4,089.18 each; two units of CH505M5chimSOSIPv4.1_G458Y_C_SORTA/GnT at $4,089.18 each; and two units of DHVI AU at $87.75 each. The materials represent specialized research reagents utilized in vaccine development and immunological studies, with the majority of the contract value ($32,713.44) allocated to the three chimeric envelope protein variants and the remaining $175.50 designated for ancillary research supplies.